HEOR Evidence Synthesis Director

Position Summary

The Director, HEOR Evidence Synthesis is part of the HEOR Evidence Synthesis and Strategy (HEOR-ESS) sub‑team and serves as the HEOR evidence synthesis lead ensuring that HEOR evidence generated internally and externally is leveraged to support pre‑launch, launch and lifecycle management of therapies. The HEOR-ESS sub‑team is part of a larger Clinical Data Science and Evidence (CDSE) team which sits within the CMR department.

The mission of the HEOR-ESS team is to develop the HEOR evidence strategy that corresponds with the strategy of the larger organization and synthesize and disseminate impactful real‑world evidence generated by the RWE and modeling teams within CDSE. The Director, HEOR Evidence Synthesis is responsible to work closely with the HEOR Strategy Director to ensure that stakeholder evidence needs (RWE or modeling) are incorporated in the HEOR strategy and evidence generated and referenced internally and externally is scientifically rigorous and aligned to NNI strategy throughout product life cycle.

In addition, the Director, HEOR synthesis will monitor and engage with external bodies such as ICER, conducting health technology reviews of NNI products in the US. The incumbent will also serve as an internal reviewer/approver of research protocols as well as enable pull‑through of synthesized evidence being developed for proactive and reactive communication with external customers, including materials for proactive promotion as well as reactive medical exchange.

In addition, the incumbent will lead the execution and dissemination of any rapid data analytics requests from stakeholders to support their internal strategy.

This position reports to the Senior Director, HEOR Evidence Strategy and Synthesis. The Director, HEOR Evidence Synthesis works in tandem with the HEOR Strategy Director and very closely with a number of NNI functions including Clinical Development, Medical Affairs, Real World Evidence teams, Legal, Regulatory, Market Access and Public Affairs, Marketing and Sales, and other key internal stakeholders. In the execution of specific projects, the Director, HEOR Evidence Synthesis will work within the NNI cross‑functional project team to provide scientific expertise to the research protocol and analysis plan and interpret results with the external customer in mind.

Throughout the conduct of research, this individual will take the lead on all aspects of communication and dissemination associated with the research activity.

• The incumbent must understand the US market landscape, external stakeholder needs, and how these culminate into an HEOR strategy. In addition, she/he must work in tandem with the HEOR Strategy Director and lead communication activities in the areas of RWE and HEOR.
• Develop institutional knowledge of internal stakeholders who utilize RWE, economic models, and rapid data analytics and develop pathways such that the impact from the evidence is timely and tailored to the needs of the customer‑facing team.
• Provide communication expertise working alongside advocates from medical and commercial teams and in partnership with others within the HEOR-ESS team, and oversee the dissemination of all HEOR & RWE studies for the portfolio of therapeutic areas.
• Actively seek and display understanding of therapeutic area/Brand strategy, and map strategy to research conduct and output.
• Develop understanding of needs of each existing internal and external customer and monitor gaps in overall value of the Brand/s and relative value in the market.
• Work with key internal stakeholders to ensure that research studies are aligned with the needs of the internal stakeholders and external customers.
• Develop & solidify pathway for use of evidence in promotional situations and connected to medical communication.
• Continually communicate with internal stakeholders while synthesizing evidence across the therapeutic area to ensure and increase visibility and use of the team’s work.
• Design Evidence Synthesis Package and other tools and materials based on the research for Novo Nordisk internal communication and also, when applicable, for external…